Caitong International Asset Management Co., LTD Tg Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 69 shares of TGTX stock, worth $2,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 3,106
97.78%
Holding current value
$2,533
Previous $93.5 Million
97.09%
% of portfolio
0.0%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$573 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$418 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$273 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$121 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$105 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.33B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...